Peptide-drug-conjugates for Personalized, Targeted Therapy of Chronic Lymphocytic Leukemia
NCT02828774
·
clinicaltrials.gov ↗
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
CLL
Interventions
OTHER:
there will be no intervention.
Sponsor
Assuta Medical Center